We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 41-60 of 10,000 results
  1. Post-recurrence survival analysis in patients with oligo-recurrence after curative esophagectomy

    Background

    Recurrent esophageal cancer is associated with dismal prognosis. There is no consensus about the role of surgical treatments in patients...

    **-Chung Tsai, Hung-Che Chien, ... Han-Shui Hsu in BMC Cancer
    Article Open access 09 June 2022
  2. β-blockers and breast cancer survival by molecular subtypes: a population-based cohort study and meta-analysis

    Background

    The association between use of β-blockers and breast cancer (BC) prognosis has been investigated in several observational studies, with...

    L. Lukas Løfling, Nathalie C. Støer, ... Edoardo Botteri in British Journal of Cancer
    Article Open access 20 June 2022
  3. Improve individual treatment by comparing treatment benefits: cancer artificial intelligence survival analysis system for cervical carcinoma

    Purpose

    The current study aimed to construct a novel cancer artificial intelligence survival analysis system for predicting the individual mortality...

    Jieyi Liang, Tingshan He, ... Zhiqiao Zhang in Journal of Translational Medicine
    Article Open access 28 June 2022
  4. Survival outcomes in endometrial cancer patients according to diabetes: a systematic review and meta-analysis

    Background

    Diabetes is an established risk factor for endometrial cancer development but its impact on prognosis is unclear and epidemiological...

    Lauren McVicker, Christopher R. Cardwell, ... Úna C. McMenamin in BMC Cancer
    Article Open access 20 April 2022
  5. Efficacy-effectiveness analysis on survival in a population-based real-world study of BRAF-mutated metastatic colorectal cancer patients treated with encorafenib-cetuximab

    Background

    Encorafenib-cetuximab has been approved for pretreated BRAF V600E -mutated metastatic colorectal cancer (mCRC) patients based on efficacy...

    Koen Zwart, Sietske C. M. W. van Nassau, ... Jeanine M. L. Roodhart in British Journal of Cancer
    Article 20 May 2024
  6. Post-diagnosis smoking cessation and survival of patients with head and neck cancer: a systematic review and meta-analysis

    Cigarette smoking is the main risk factor for head and neck cancer (HNC) and many HNC patients are active smokers at diagnosis. We conducted a...

    Saverio Caini, Marco Del Riccio, ... Sara Gandini in British Journal of Cancer
    Article 23 August 2022
  7. Effect of adjuvant radiotherapy on overall survival and breast cancer-specific survival of patients with malignant phyllodes tumor of the breast in different age groups: a retrospective observational study based on SEER

    Purpose

    Malignant phyllodes tumor of the breast (MPTB) is a rare type of breast cancer, with an incidence of less than 1%. The value of adjuvant...

    ** Yang, Gongyin Zhang, ... Li Lv in Radiation Oncology
    Article Open access 21 May 2024
  8. Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study

    Background

    Recently, we showed a >60% difference in 5-year survival for patients with tubo-ovarian high-grade serous carcinoma (HGSC) when stratified...

    Ashley Weir, Eun-Young Kang, ... Susan J. Ramus in British Journal of Cancer
    Article Open access 02 November 2022
  9. Artificial intelligence-based prognostic model accurately predicts the survival of patients with diffuse large B-cell lymphomas: analysis of a large cohort in China

    Background

    Diffuse large B-cell lymphomas (DLBCLs) display high molecular heterogeneity, but the International Prognostic Index (IPI) considers only...

    Huilin Peng, Mengmeng Su, ... ** Chen in BMC Cancer
    Article Open access 22 May 2024
  10. The influence of adjuvant chemotherapy dose intensity on overall survival in resected colon cancer: a multicentered retrospective analysis

    Background

    Colorectal cancer remains the second leading cause of cancer death in North America. Fluorouracil and oxaliplatin based adjuvant...

    Daniel Breadner, Jonathan M. Loree, ... Stephen A. Welch in BMC Cancer
    Article Open access 01 November 2022
  11. Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer: long-term survival analysis of the DESTINY-Breast03 trial

    Trastuzumab deruxtecan (T-DXd) demonstrated significantly improved efficacy over trastuzumab emtansine (T-DM1) in DESTINY-Breast03 (median follow-up,...

    Javier Cortés, Sara A. Hurvitz, ... Erika Hamilton in Nature Medicine
    Article Open access 02 June 2024
  12. Association between concomitant proton pump inhibitor use and survival of patients with metastatic prostate cancer receiving abiraterone acetate: a post-hoc analysis of pooled data from three randomized controlled trials

    Background

    Evidence suggests proton pump inhibitor (PPI) use may attenuate the effect of abiraterone acetate plus prednisone (AAP) in metastatic...

    Wataru Fukuokaya, Keiichiro Mori, ... Takahiro Kimura in Prostate Cancer and Prostatic Diseases
    Article 18 July 2023
  13. Genome wide DNA methylation analysis identifies novel molecular subgroups and predicts survival in neuroblastoma

    Background

    Neuroblastoma is the most common malignancy in infancy, accounting for 15% of childhood cancer deaths. Outcome for the high-risk disease...

    H. Lalchungnunga, Wen Hao, ... Gordon Strathdee in British Journal of Cancer
    Article Open access 29 September 2022
  14. CT texture analysis in predicting treatment response and survival in patients with hepatocellular carcinoma treated with transarterial chemoembolization using random forest models

    Background

    Using texture features derived from contrast-enhanced computed tomography (CT) combined with general imaging features as well as clinical...

    He An, Inderjeet Bhatia, ... Chuanmiao **e in BMC Cancer
    Article Open access 03 March 2023
  15. Standardised survival probabilities: a useful and informative tool for reporting regression models for survival data

    Background

    When interested in studying the effect of a treatment (or other exposure) on a time-to-event outcome, the most popular approach is to...

    Elisavet Syriopoulou, Tove Wästerlid, ... Therese M.-L. Andersson in British Journal of Cancer
    Article Open access 01 September 2022
  16. Integrated Bioinformatic Analysis of the Correlation of HOXA10 Expression with Survival and Immune Cell Infiltration in Lower Grade Glioma

    Homeobox A10 (HOXA10) encodes a transcription factor that regulates developmental processes. Whether HOXA10 mRNA levels in lower grade glioma (LGG)...

    Ting Wang, Mingqian Liu, Ming Jia in Biochemical Genetics
    Article 14 July 2022
  17. Analysis of clinical features, genomic landscapes and survival outcomes in HER2-low breast cancer

    Background

    Novel human epidermal growth factor receptor 2 (HER2)-directed antibody–drug conjugates prompt the identification of the HER2-low subtype....

    Juan **, Bin Li, ... **chun Hu in Journal of Translational Medicine
    Article Open access 01 June 2023
  18. Architecting the metabolic reprogramming survival risk framework in LUAD through single-cell landscape analysis: three-stage ensemble learning with genetic algorithm optimization

    Recent studies have increasingly revealed the connection between metabolic reprogramming and tumor progression. However, the specific impact of...

    **nti Sun, Minyu Nong, ... Peng Zhang in Journal of Translational Medicine
    Article Open access 15 April 2024
  19. Tumour infiltrating lymphocytes and survival after adjuvant chemotherapy in patients with gastric cancer: post-hoc analysis of the CLASSIC trial

    Background

    Only a subset of gastric cancer (GC) patients with stage II–III benefits from chemotherapy after surgery. Tumour infiltrating lymphocytes...

    Drolaiz H. W. Liu, Young-Woo Kim, ... Heike I. Grabsch in British Journal of Cancer
    Article 07 April 2023
  20. Sample average treatment effect on the treated (SATT) analysis using counterfactual explanation identifies BMT and SARS-CoV-2 vaccination as protective risk factors associated with COVID-19 severity and survival in patients with multiple myeloma

    Patients with multiple myeloma (MM), an age-dependent neoplasm of antibody-producing plasma cells, have compromised immune systems and might be at...

    Amit Kumar Mitra, Ujjal Kumar Mukherjee, ... Melissa A. Haendel in Blood Cancer Journal
    Article Open access 07 December 2023
Did you find what you were looking for? Share feedback.